在家改善药物安全:对儿科患者父母的教育干预措施的系统审查
S Giva1,2,3, F MacDonald3, B Cleary3,4
1Neonatology Department, Rotunda Hospital, Dublin 1, Ireland.
Acta paediatrica (Oslo, Norway : 1992)
|January 11, 2026
概括
结构化的教育干预措施显著提高了护理人员的药物知识,并减少了家中儿科药物错误. 这些策略提高了患者的安全性和护理人员在出院后的信心.
科学领域:
- 儿科患者的安全性
- 药物管理 药物管理
- 卫生识字 卫生识字
背景情况:
- 药物错误对儿科患者构成重大风险.
- 关于有效的护理人员教育治疗后药物管理的证据有限.
研究的目的:
- 系统地审查以护理人员为中心的教育干预措施的有效性.
- 评估对儿科药物知识和错误的影响.
主要方法:
- 按照PRISMA指南 (2005-2025) 进行系统审查.
- 包括对在药物治疗下出院的儿科患者 (0-16岁) 的研究.
- 评估了以护理人员为重点的教育干预措施.
主要成果:
- 七项研究 (RCT,ITS,横截面) 涉及1293名参与者.
- 多组分干预改善了知识 (p<0.001) 并减少了剂量错误 (12%-54%).
- 在一项研究中,依从性表现有改善;因异质性而排除了元分析.
结论:
- 结构化的教育干预措施提高了护理人员的理解,并减少了家庭药物错误.
- 识字敏感的材料,咨询和剂量工具提高了儿科患者的安全性.
- 需要进一步研究长期影响和成本效益.
相关概念视频
Pharmacokinetics in Pediatric Patients: Drug Excretion
201
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
201
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
239
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
239
Pharmacokinetics in Pediatric Patients: Drug Metabolism
185
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
185
Pharmacokinetics in Pediatric Patients: Drug Distribution
249
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
249
Drug Dosing: Infants and Children
241
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
241
Drug Dosing: Geriatric Patients
217
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
217


